Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.43 |
| ▸ | MAPT | P10636 | 8/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.43 |
| ▸ | NPC1 | O15118 | 6/20 | 0.43 |
| ▸ | RAB9A | P51151 | 6/20 | 0.43 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | STAT1 | P42224 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 5/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.41 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.39 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.39 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.38 |
| ▸ | GRK2 | P25098 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10018431 | 1.00 | PIK3CA (0.45) | PIK3CAKDM4EMAPTALDH1A1NPC1 | |
| SCHEMBL16355319 | 0.97 | KDM4E (0.43) | PIK3CAKDM4EMAPTALDH1A1NPC1 | |
| SCHEMBL15959617 | 0.96 | PIK3CA (0.45) | PIK3CAKDM4EMAPTALDH1A1NPC1 | |
| SCHEMBL16355358 | 0.92 | GRM5 (0.44) | PIK3CAKDM4EMAPTALDH1A1NPC1 | |
| SCHEMBL15959614 | 0.92 | KDM4E (0.45) | PIK3CAKDM4EMAPTALDH1A1NPC1 | |
| SCHEMBL30911080 | 0.91 | GRM5 (0.44) | PIK3CAKDM4EMAPTALDH1A1NPC1 | |
| SCHEMBL15949810 | 0.91 | GRM5 (0.44) | PIK3CAKDM4EMAPTALDH1A1NPC1 | |
| SCHEMBL30911081 | 0.91 | GRM5 (0.44) | PIK3CAKDM4EMAPTALDH1A1NPC1 | |
| SCHEMBL16355344 | 0.90 | GRM5 (0.43) | PIK3CAKDM4EMAPTALDH1A1NPC1 | |
| SCHEMBL17805249 | 0.88 | NPC1 (0.44) | PIK3CAKDM4EMAPTALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10593884-B2 | Organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2020-03-17 | — | — | US | disclosed |
| US-20180006235-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2018-01-04 | — | — | US | disclosed |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | SFC CO., LTD. (KR) | 2017-11-30 | — | — | US | disclosed |
| WO-2016111254-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | 保土谷化学工業株式会社 | 2016-07-14 | — | — | WO | disclosed |
| US-9123897-B2 | Benzotriazole derivatives and organic electroluminescent devices using the derivatives | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-09-01 | — | — | US | disclosed |
| US-9123897-B2 | Benzotriazole derivatives and organic electroluminescent devices using the derivatives | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-09-01 | — | — | US | disclosed |
| US-20140374721-A1 | NOVEL BENZOTRIAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE DERIVATIVES | HODOGAYA CHEMICAL CO., LTD (JP) | 2014-12-25 | — | — | US | disclosed |
| US-20140374721-A1 | NOVEL BENZOTRIAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE DERIVATIVES | HODOGAYA CHEMICAL CO., LTD (JP) | 2014-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10593884-B2 | Organic electroluminescent device | AHR, SLC18A1, KCNH1 | PIK3CA 3361/4885KDM4E 1822/4885MAPT 2734/4885 |
| US-20180006235-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | AHR, SLC18A1, KCNH1 | PIK3CA 3361/4885KDM4E 1822/4885MAPT 2734/4885 |
| US-20170346009-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | AHR, SLC18A1, ARNT | PIK3CA 3322/4885KDM4E 1225/4885MAPT 2246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.